Medgenics, Inc. Reports First Quarter 2013 Financial Results
5/9/2013 7:59:59 AM
More...
|
Medgenics, Inc. Announces Results of 2013 Annual Meeting of Stockholders
5/1/2013 7:35:57 AM
More...
|
Medgenics, Inc. Reports "Encouraging" Data From Epodure Biopump Trial
4/25/2013 8:45:10 AM
More...
|
Medgenics, Inc. Receives Notice of Allowance From the U.S. Patent Office for Claims That Expand IP for Its Platform Technology to Additional Therapeutic Proteins
4/22/2013 12:33:47 PM
More...
|
Medgenics, Inc. to Present at the 12th Annual Needham Healthcare Conference
4/18/2013 7:32:32 AM
More...
|
Medgenics, Inc. Announces Exercise by Underwriters of Over-Allotment Option
3/26/2013 11:05:41 AM
More...
|
Medgenics, Inc. to Present at the 25th Annual Roth Conference
3/15/2013 8:18:24 AM
More...
|
Medgenics, Inc. Reports 2012 Financial Results
3/14/2013 9:22:55 AM
More...
|
Medgenics, Inc. Launches First Clinical Trial in Hepatitis to Use INFRADURE Tissue Treatment
1/30/2013 9:54:47 AM
More...
|
Medgenics, Inc. Key Patent Claims Allowed in Japan Protecting Core Technology to be Used in Hepatitis Treatment
12/6/2012 11:01:48 AM
More...
|
|